A.R.T. Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,954
Closed -$1.22M 1824
2019
Q3
$1.22M Sell
22,954
-2,341
-9% -$120K 0.06% 463
2019
Q2
$1.29M Sell
25,295
-27,000
-52% -$1.26M 0.07% 371
2019
Q1
$2.71M Buy
+52,295
New +$2.54M 0.16% 163
2018
Q4
Sell
-19,467
Closed -$1M 1758
2018
Q3
$1M Buy
+19,467
New +$953K 0.05% 576
2018
Q2
Sell
-50,967
Closed -$1.81M 1841
2018
Q1
$1.81M Buy
+50,967
New +$2M 0.07% 425
2017
Q3
Sell
-46,500
Closed -$2.72M 1755
2017
Q2
$2.72M Buy
+46,500
New +$2.42M 0.14% 179
2017
Q1
Sell
-13,700
Closed -$720K 1785
2016
Q4
$720K Buy
+13,700
New +$663K 0.04% 599
2016
Q3
Sell
-71,401
Closed -$2.72M 1257
2016
Q2
$2.72M Buy
71,401
+50,520
+242% +$2.22M 0.14% 216
2016
Q1
$860K Buy
20,881
+3,300
+19% +$136K 0.04% 649
2015
Q4
$852K Sell
17,581
-1,997
-10% -$88.8K 0.04% 643
2015
Q3
$783K Buy
19,578
+3,954
+25% +$173K 0.03% 715
2015
Q2
$626K Buy
+15,624
New +$539K 0.02% 909

Other funds holding SYNH

A.R.T. Advisors's SYNH Position: Q4 2019 in Review

A.R.T. Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2019, closing a stake of 22,954 shares — an estimated $1.22M sold.

A.R.T. Advisors first reported a position in SYNH in Q2 2015 and held it in 12 quarters. The position peaked at $2.72M in Q2 2016. 246 funds tracked by Wall St. Rank hold SYNH as of Q4 2019.

  • A.R.T. Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 22,954 Syneos Health, Inc. Class A Common Stock shares in Q4 2019, an estimated $1.22M.
  • A.R.T. Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 12 quarters.
  • A.R.T. Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $2.72M in Q2 2016.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.